Original news and analysis on international IP policy
At Intellectual Property Watch, a list of the top 25 posts of 2010 reveals your - our readers’ - top interests and tells the tale of the past year. It also is a reminder that quality reporting needs support. Please subscribe to IP-Watch via our website, or contact the director at wnew@ip-watch.ch.
There could be some good news in 2011 for poor populations concerned about the impact of devastating pandemic diseases. Nations last week reached some breakthroughs behind closed doors in the sensitive international negotiations on finding a way to ensure all global citizens can obtain vaccines in the face of pandemics, according to a leading official in the talks. But some observers said problems remain in establishing clear rules for fair access and benefit-sharing of viruses and vaccines.
The United States Ambassador to the United Nations in Geneva this week offered a frank assessment of the UN system of dealing with pandemic diseases, and defended the need for governments to negotiate in secret to work out remaining differences.
In what may be the first legal reference to newly adopted international rules on sharing the benefits of and access to genetic resources, non-governmental groups have sent letters to top European health officials reminding them of these obligations in the context of influenza viruses and access to vaccines - a topic under debate this week at the World Health Organization.
The most recent outbreak of pandemic influenza was mild, but the World Health Organization is still working on a plan of what to do should another, more severe outbreak ever occur. States will come together this month in another attempt to finalise this plan.
Canada's Parliament has the power to save lives of millions afflicted with HIV around the world if they will act to ease intellectual property-related restrictions on their access to medicines, Canadian civil society groups said today.
The end of the year is bringing many changes in intellectual property-related policy offices in Geneva and the capitals. Some of these changes include top offices at the World Intellectual Property Organization, the World Health Organization, South African government, United States government, and a global internet body. Intellectual Property Watch Subscribers can read the details here.
The US Food and Drug Administration heard from myriad pharmaceutical companies, patient groups, and other stakeholders last week as the agency considers how to create an abbreviated pathway to bring more biologic drugs to market.
"Instead of re-hashing old debates about patents, patients and profits, forward-looking pharmaceutical executives should consider new ways of ensuring that medicines reach all patients who need them," writes John Erickson, one of the researchers who discovered the HIV medicine recently licensed by the National Institutes of Health to the Medicines Patent Pool.
Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.
NAGOYA, JAPAN - With the clock ticking and less than a day to go before a draft of a legally binding instrument to prevent biopiracy is due to be presented to the assembly of a major United Nations meeting on biodiversity, delegations kept trying to find acceptable language, with different echoes coming from the negotiating room. Meanwhile, Canadian indigenous people convened a press briefing today (21 October) to charge that Canada was trying to block the negotiations and deny their human rights.
The World Health Organization has moved responsibility for intellectual property and innovation issues out of the direct control of the WHO director general and into the company of information, evidence and research, according to sources.